Tharimmune (THAR)
NASDAQ:THAR
US Market
Holding THAR?
Track your performance easily

Tharimmune (THAR) Financial Statements

63 Followers

Tharimmune Financial Overview

Tharimmune's market cap is currently ―. The company's EPS TTM is $-47.92; its P/E ratio is -0.06; Tharimmune is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.33M$ 2.44M$ -2.47M$ -1.82M$ -2.33M
EBITDA$ -2.33M$ 2.44M$ -2.47M-$ -2.33M
Net Income Common Stockholders$ -2.33M$ -2.26M$ -2.47M$ -1.82M$ -2.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.90M$ 8.43M$ 10.94M$ 2.69M$ 3.90M
Total Assets$ 8.26M$ 8.89M$ 10.95M$ 3.17M$ 4.60M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.90M$ -8.43M$ -10.94M$ -2.69M$ -3.90M
Total Liabilities$ 1.56M$ 1.84M$ 1.82M$ 1.41M$ 1.53M
Stockholders Equity$ 6.69M$ 7.05M$ 9.13M$ 1.76M$ 3.08M
Cash Flow-
Free Cash Flow$ -2.20M$ -2.80M$ -1.40M-$ -1.51M
Operating Cash Flow$ -2.20M$ -2.80M$ -1.40M$ -924.29K$ -1.51M
Investing Cash Flow-----
Financing Cash Flow$ 1.65M$ 317.12K$ 9.66M$ -306.01K$ 1.85M
Currency in USD

Tharimmune Earnings and Revenue History

Tharimmune Debt to Assets

Tharimmune Cash Flow

Tharimmune Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis